Home
Consortium presenting at the ASTMH 65th Annual Meeting
In September, the Pediatric Praziquantel Consortium got acceptance of the abstract ’Outcome of two phase I relative bioavailability studies in healthy volunteers after administration of the new pediatric ODT formulations of racemate Praziquantel (rac-PZQ) and of the active enantiomer of Praziquantel (L-PZQ)’ for oral presentation at ASTMH* (November 13-17 – Atlanta, US). The presentation will be held on November 16 in the context of the Scientific Session ‘Schistosomiasis and Other Trematodes: Transmission and Treatment’ at the Meeting.
Beyond the presentation, representatives from Consortium partners, including from the US affiliate of Merck KGaA (Darmstadt, Germany), Swiss TPH (Tropical & Public Health Institute) and SCI (Schistosomiasis Control Initiative), will be attending ASTMH to contribute to dialogues and exchanges in the area of neglected tropical diseases; Consortium partners will be available to share progresses and respond to any specific questions on the Pediatric PZQ program during ASTMH as well as during the COR-NTD meeting proceeding the ASTMH conference.”
*ASTMH: American Society of Tropical Medicine & Hygiene